Tipping Point: Biosimilars, Emerging Markets, and Public-Private Engagement to Promote Global Health

Biosimilars, also known as follow on biologics, are complex biotechnology drugs that are similar, but not identical, to original biologic drug forms, and represent potential lower cost versions that may improve access. Yet biologics and their biosimila…


Not fully harmonized: Differences in biotechnology patenting between Europe and the United States

There has been a trend of worldwide harmonization of patent laws. Due to the continuing harmonization, examination of patents in Europe and the United States are very similar.  However, examination standards between the two patent offices can differ. …


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog